Login
Toggle navigation
Videos
Categories
Trending
Company 'Latvijas Gāze' is reluctant to easily part with the one and a half million lati fine imposed by the Competition Council.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Aigars Kalvītis is Chairman of the Board
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Remon Vos Discusses CTP's Resilient Growth and Future Plans at Expo Real | Remon Vos, President, CTP NV.
00:10:00
David Hunt on Strategic Leadership, Global Markets, and the Future of Asset Management | David Hunt, CEO , PGIM.
00:00:00
Kathriena Greenwell, M.D. Bariatric Surgery (Weight-loss Surgery)
00:10:00
Discipline and Experience: Key to Success in Emerging Markets
00:10:00
Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility.
00:10:00
Image Resources: Advancing Mineral Sands Projects from Exploration to Production
00:10:00
HSBC's Forward Momentum: Reflections on Record Earnings and Future Strategies | Noel Quinn, CEO , HSBC.
00:10:00
Santa Cruz Silver Mining: Enhancing Production and Exploration Opportunities
00:10:00
Colonial Coal (CAD) - Sales Process Started as Met Coal Prices Excite | David Austin, CEO, Colonial Coal International CorpCAD:CVE
00:10:00
Utility Shutoff Risks and Regional Impacts Amid Rising Energy Costs
00:10:00
Aston Minerals: Investigating Ontario's Gold and Nickel | Russell Bradford, Managing Director, Aston Minerals Ltd. (IE)
00:10:00
Explore the Venture capital view of the investment process|Andrew Armour,Managing Partner,Chaac Ventures